Pseudopterigium

01Pathophysiology

Pseudopterygium develops through a fundamentally different mechanism than true pterygium, and understanding this distinction is the core concept being tested.

When the corneal epithelium is damaged or lost (from a chemical burn, peripheral ulcer, thermal injury, or inflammatory conditions like Stevens-Johnson syndrome), the adjacent conjunctival tissue responds by migrating onto the denuded corneal surface as part of the wound-healing response. The conjunctiva essentially "fills in" the epithelial defect, creating an adhesion between the conjunctival fold and the corneal stroma. This is a reparative, secondary process, driven by fibroblast proliferation and scar tissue formation at the site of prior injury.

Critically, this process does not involve elastotic degeneration of subconjunctival collagen, which is the hallmark histopathological finding of true pterygium. True pterygium arises from chronic ultraviolet radiation damage to limbal stem cells and subconjunctival connective tissue, leading to actinic elastosis. Pseudopterygium, by contrast, shows fibrosis, chronic inflammatory infiltrate, and neovascularization without elastotic changes.

Because the adhesion forms only at the original site of corneal damage, only the head (leading edge) of the pseudopterygium is adherent to the corneal surface. The body and the neck of the lesion are not fused to the underlying sclera or cornea. This explains the positive probe test: a glass rod or metal probe can be slid freely beneath the body of the pseudopterygium. In true pterygium, the entire structure is firmly adherent to the underlying tissue because it represents progressive subepithelial fibrovascular invasion through a destroyed Bowman's layer.

The location of pseudopterygium is dictated by the site of original corneal injury, which means it can occur anywhere on the corneal circumference. This contrasts sharply with true pterygium, which almost always originates from the nasal interpalpebral conjunctiva because this zone receives the highest UV exposure due to peripheral light focusing by the cornea (the "coroneo effect").

Stocker's line, a curvilinear iron deposition line (hemosiderin in the corneal epithelium) found at the advancing edge of a true pterygium, is characteristically absent in pseudopterygium. Stocker's line forms because of chronic, slow, progressive growth that allows tear film iron to deposit at the leading edge. Pseudopterygium does not exhibit this slow progressive march, so no iron line develops.

02Classification and Clinical Manifestation

The clinical presentation varies depending on the underlying cause. A patient with a history of alkali burn may present with a broad, vascularized membrane extending from severely scarred conjunctiva onto an opacified cornea, often accompanied by symblepharon (adhesion of palpebral to bulbar conjunctiva) and fornix shortening. By contrast, a patient who had a small peripheral corneal ulcer may develop a localized, thin fold of conjunctiva bridging onto the healed ulcer site.

03Diagnostic Workup

The best initial test is a thorough slit-lamp examination combined with the patient's clinical history. The exam will reveal a conjunctival fold or flap adherent to the cornea. You should note the location of the lesion (non-nasal location is a strong clue) and look for associated findings such as corneal scarring at the adhesion site, symblepharon formation, or evidence of limbal stem cell deficiency.

The probe test is the single most important clinical maneuver for distinguishing pseudopterygium from true pterygium, and it is the detail most likely to appear in a vignette stem. You gently slide a probe (or glass rod) beneath the body of the lesion. If it passes freely, the lesion is a pseudopterygium. If the body is firmly adherent and the probe cannot be advanced, it is a true pterygium.

Histopathology serves as the gold standard for confirmation but is available only after surgical excision. The hallmark is the absence of elastotic degeneration. True pterygium specimens characteristically show Bowman's layer destruction, elastotic (actinic) degeneration of subepithelial collagen, and often a prominent fibrovascular core.

Anterior segment optical coherence tomography (OCT) has emerged as a helpful adjunctive tool. It can demonstrate a clear space beneath the body of a pseudopterygium, correlating with the clinical probe test, and can delineate the depth of corneal stromal involvement to guide surgical planning.

04Management and Treatment

Step 1: Address the underlying cause. Before any surgical intervention, the corneal and conjunctival surface must be stable. Active inflammation or ulceration should be treated. If the cause was a chemical burn, ensure adequate initial irrigation and control of ongoing inflammation.

Step 2: Determine visual significance. If the pseudopterygium does not threaten the visual axis and the patient has minimal symptoms, conservative management with artificial tears and monitoring is appropriate. Many pseudopterygia remain stable once the original insult has healed, unlike true pterygia which tend to progress.

Step 3: Surgical excision. For visually significant lesions, the pseudopterygium is dissected from the corneal surface. Because only the head is adherent, the dissection plane is generally straightforward. The bare scleral or corneal bed is then covered with either a conjunctival autograft (harvested from the superior bulbar conjunctiva) or an amniotic membrane transplant to reduce scarring and recurrence.

Step 4: Manage corneal opacity. If the cornea beneath the excised pseudopterygium has significant stromal scarring that limits visual recovery, lamellar keratoplasty (partial thickness corneal transplant) may be needed as a secondary procedure.

Step 5: Post-operative care. Topical prednisolone acetate 1% is initiated four times daily and tapered gradually over 4 to 6 weeks to control inflammation and reduce fibrosis. A topical fluoroquinolone antibiotic (moxifloxacin 0.5% or ofloxacin 0.3%) is used four times daily for 7 to 14 days for infection prophylaxis. Preservative-free artificial tears are continued for comfort and surface lubrication.

Contraindications and special considerations: In patients with severe limbal stem cell deficiency (common after extensive chemical burns), simple excision will fail because the corneal epithelium cannot regenerate. These patients require limbal stem cell transplantation before or concurrent with pterygium excision. Without restoring the stem cell population, the conjunctival tissue will simply re-invade the corneal surface.

Recurrence of pseudopterygium after surgery is less common than recurrence of true pterygium, provided the underlying cause has been adequately treated and the ocular surface is stable.

05Differential Diagnosis and Distractors

06Traps and High-Yield Pearls

The most common way students get questions on pseudopterygium wrong is by confusing it with true pterygium and selecting UV-related or nasal-location-based answers when the vignette clearly describes a different mechanism. The vignette will typically plant a history of ocular trauma or chemical burn earlier in the stem, and the student who does not connect that history to the conjunctival-corneal adhesion will default to "pterygium" and choose the wrong diagnosis.

The second major trap involves the probe test. A well-constructed question may describe a pterygium-like lesion and then ask for the best clinical maneuver to differentiate true from pseudo. Students who are unfamiliar with the probe test may choose biopsy or imaging, both of which are less practical and not the expected answer. The probe test is the key bedside differentiator.

Another pitfall is location. If the vignette describes a wing-shaped conjunctival growth at the temporal or inferior limbus, this should immediately raise suspicion for pseudopterygium over true pterygium. True pterygium in the temporal position is uncommon; a non-nasal location combined with a relevant history essentially clinches the diagnosis.

Finally, be aware of the management trap: students sometimes select "mitomycin-C application" or "conjunctival autograft to prevent recurrence" as if managing a true pterygium. While surface reconstruction techniques overlap, the more important management principle for pseudopterygium is treating the underlying cause and ensuring ocular surface stability. Without addressing limbal stem cell deficiency or ongoing inflammation, no graft will hold.

The core competency being tested is the ability to integrate clinical history (preceding trauma or inflammation) with examination findings (location, probe test, absence of Stocker's line) to distinguish a secondary, reparative process from a primary degenerative one.